- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
CSL Ltd (CSLLY)
CSL Ltd stock price live, this page displays OTC CSLLY stock exchange data. View the CSLLY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the CSL Ltd real time stock price chart below.
What Is the CSL Ltd Stock Price Today?
The CSL Ltd stock price today is 30.92.
What Is the Stock Symbol for CSL Ltd?
The stock ticker symbol for CSL Ltd is CSLLY.
Is CSLLY the Same as $CSLLY?
$CSLLY is a common way to refer to the CSL Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does CSL Ltd Trade On?
CSL Ltd is listed and trades on the OTC Markets stock exchange.
Is CSL Ltd a Good Stock to Buy?
Determining whether CSL Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current CSL Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CSLLY quote. (ISIN: US12637N2045)
What Is the CSL Ltd Stock Price Today?
The CSL Ltd stock price today is 30.92.
What Is the Stock Symbol for CSL Ltd?
The stock ticker symbol for CSL Ltd is CSLLY.
Is CSLLY the Same as $CSLLY?
$CSLLY is a common way to refer to the CSL Ltd ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does CSL Ltd Trade On?
CSL Ltd is listed and trades on the OTC Markets stock exchange.
Is CSL Ltd a Good Stock to Buy?
Determining whether CSL Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current CSL Ltd share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CSLLY quote. (ISIN: US12637N2045)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
30.76
31.14
52 wk Range
16.01
36.28
CSLLY is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
30.7631.14
52 wk Range
16.0136.28
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.16%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.16%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CSLLY Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
28.40
Downside
-8.15%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 4 consecutive years
Csl Limited receives Investment Bank Analyst Rating Update- Investing.com
Pro
CSL stock hit a 6-1/2 mth high today, here’s why- Investing.com
Csl Limited receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Csl Limited receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Why is CSL stock rallying today?- Investing.com
Csl Limited receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 28.40
(-8.15% Downside)
Earnings
Latest Release
Aug 17, 2026
EPS / Forecast
-6.20 / --
Revenue / Forecast
7.47B / --
Compare CSLLY to Peers and Sector
Metrics to compare | CSLLY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCSLLYPeersSector | |
|---|---|---|---|---|
P/E Ratio | −22.9x | 27.5x | −0.4x | |
PEG Ratio | 0.12 | 0.11 | 0.00 | |
Price / Book | 4.0x | 2.6x | 2.6x | |
Price / LTM Sales | 3.7x | 2.7x | 3.1x | |
Upside (Analyst Target) | −8.2% | 40.6% | 48.1% | |
Fair Value Upside | Unlock | 10.6% | 6.3% | Unlock |
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. The company’s therapeutic areas includes Immunoglobulins, Immunology, Immunology Haematology, Cardiovascular and Renal, and Vaccines. It also licenses CSL intellectual property. It also develops vaccines for the prevention of infectious disease. The company has strategic collaboration with Dutch biotech company VarmX BV for the development of VMX-C001 to help restore blood coagulation in patients requiring urgent surgery. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the CSL (CSLLY) Stock Price Today?
The CSL stock price today is 30.92 USD.
What Stock Exchange Does CSL Trade On?
CSL is listed and trades on the OTC Markets.
What Is the Stock Symbol for CSL?
The stock symbol for CSL is "CSLLY."
Does CSL Pay Dividends? What’s The Current Dividend Yield?
The CSL dividend yield is 2.16%.
What Is the CSL Market Cap?
As of today, CSL market cap is 59.11B USD.
What Is CSL's Earnings Per Share (TTM)?
The CSL EPS (TTM) is -5.35.
From a Technical Analysis Perspective, Is CSLLY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has CSL Stock Split?
CSL has split 1 times.
How Many Employees Does CSL Have?
CSL has 29000 employees.
What is the current trading status of CSL (CSLLY)?
As of Aug 30, 2026, CSL (CSLLY) is trading at a price of 30.92 USD, with a previous close of 31.34 USD. The stock has fluctuated within a day range of 30.76 USD to 31.14 USD, while its 52-week range spans from 16.01 USD to 36.28 USD.
What Is CSL (CSLLY) Price Target According to Analysts?
The average 12-month price target for CSL is 28.40 USD, with a high estimate of 28.4 USD and a low estimate of 28.4 USD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an -8.15% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.